Skip to content
Intrinsic value · Buy/Sell verdict · scores — free· 500 Nifty 500 stocks· EOD 2026-06-15

Supreme Petrochem Ltd.

SPLPETRO · NSE · Basic Materials

₹700.75
-1.35 (-0.19%)
Our verdict
Hold58/100
Quality63
Valuation48
Momentum47
Financial trend75
Intrinsic value
Our fair value
₹655.98
Fairly valued
Price ₹700.75Range ₹557.58₹754.38

With a 20% margin of safety, our buy-below price is ₹524.78.

A
Financial health 100/100
Altman Z 9.11 · Safe zone

Piotroski F-score 4/9 — quality of earnings & balance sheet.

Investability checklist

Passed 5 of 13 checks38/100
  • ROE above 15%14.3%
  • Low debt (D/E < 0.5)0.06x
  • Positive free cash flow
  • Revenue growth > 10%5%
  • Earnings growing58%
  • Net margin ≥ 10%6.1%
  • Current ratio > 1.52.01
  • Below our fair value
  • Margin of safety ≥ 20%
  • Above 200-day average
  • Above 50-day average
  • Positive 1-year return
  • Altman Z in safe zoneZ 9.11
  • Piotroski ≥ 74/9

1-year price

EOD · 2026-06-15
1W
+4.9%
1M
+0.8%
3M
+1.5%
6M
+6.4%
1Y

Our scores

Durability63
Valuation57
Momentum47
Analyst consensus target ₹791.5 (+13%) · 2 analysts

Key fundamentals

Market cap
₹13,177 Cr
P/E ratio
39.9
P/B ratio
5.54
EPS (TTM)
₹17.55
ROE
14.3%
Debt / Equity
0.06x
Profit margin
6.1%
Free cash flow
₹-15 Cr
52-week high
₹876.58
-20.06% from high
52-week low
₹501.45
Dividend yield
1.5%
Beta
-0.04

SWOT snapshot

Strengths

  • Lightly leveraged balance sheet.
  • Financially solid — Altman Z 9.11.

Opportunities

  • Earnings growing (58% YoY).

About Supreme Petrochem Ltd.

Supreme Petrochem Limited manufactures and sells polystyrene, expandable polystyrene, masterbatches and compounds of styrenics and other polymers, and extruded polystyrene insulation board in India and internationally. It provides general purpose and high impact polystyrene for injection moulding, extrusion, thermoforming, and blow moulding applications; expandable polystyrene (EPS) used in road and railway construction, and food industry; and acrylonitrile butadiene styrene

More in Chemicals

Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.